Patients with epilepsy, Parkinson's patients, patients with functional paralysis of the lower limbs and need rehabilitation training, and some patients with diseases caused by nerve signal disorders have all participated in Ruikang Group's clinical trials.

Pieces of Power Type 1 chips customized according to their own genes are implanted into their skull.

Although it seems that the risk of this clinical trial is very high, after all, it is necessary to install a chip in the human brain.

But the actual experiment was very safe and smooth.

Electronic chips can actually be regarded as the most stable product among human electronic products. It is rare to see electronic chips explode.

Although some servers and computers sometimes have overloaded temperatures and will indeed catch fire or even explode.

However, the hardware that catches fire is usually the motherboard responsible for stabilizing the voltage, the overloaded graphics card, and the power supply. Most of the explosions are these three hardware.

In addition to a very small single crystal silicon wafer in the integrated circuit chip, it is epoxy resin or ceramic packaging material.

Usually, if a fault occurs, the load is too large and burned, the internal electrode tube may be broken, but it is far from the point of explosion.

So in terms of safety, it is actually very safe to put chips into your head.

In particular, Ruikang staff also limit the rated frequency of the chip very much. Even if it runs to the maximum power, it only uses 80% of the chip utilization rate and will not fully utilize the performance. This is also to avoid burning the chip by running at high loads.

What's more, in order to ensure insurance, a layer of biofilm was coated with the patient's own cell tissue outside the chip.

On the one hand, this film is to prevent the implant from repelling the human body, and on the other hand, it is to prevent the chip from malfunctioning, and there is a protective film blocking it and it will not damage the patient's brain.

In addition, there is also a circulating water cooling for cooling the chip in the protective film, which can keep the working temperature of the chip at 37 degrees of the human body's natural temperature.

This is a big breakthrough. The CPU used in normal computers generally has a working temperature between 45-75 degrees. If you run a large software, the temperature may rise to between 70 degrees and 85 degrees. This temperature cannot be implanted into the brain, otherwise the human brain can be roasted.

Thanks to the emergence of carbon-based chips, the reduction in power consumption of the biodynamic 1 chip itself, the intelligent temperature control system, and the water cooling on the outer membrane, the working temperature is barely reduced to the same as the human body temperature.

A chip that is as small as a fingernail but integrates so many subsystems, can be regarded as the peak level of human craftsmanship.

If Ruikang Group, ten years ago, was definitely not able to make this product.

That is, Chen Changan spent nearly 100 billion US dollars on the prosthetic body research and development base every year. After four or five years, he finally made such a craft crystallization.

Biodynamic Type 1 brain mechanism chip has been steadily conducting more than 100 phase 2 and 3 clinical trials in clinical centers.

Every patient who has a brain mechanism chip implanted has achieved very good treatment results.

Sixty-two patients with refractory epilepsy, 51 Parkinson's patients and 46 patients with lower limb paralysis improved after the chip was implanted.

Both epilepsy patients and Parkinson's patients have been completely controlled and will not recur.

After the chip was implanted, the rehabilitation effect was also very good with the help of biodynamic type 1. Some patients who had very little natural rehabilitation effect after implanting the chip, successfully stood up from the bed and started rehabilitation tremblingly.

Among the 46 patients, more than half of the subjects successfully walked alone without the support of a rehabilitation doctor. Although they were unable to run and were trembling when walking, they could at least walk independently. This result was already very surprising.

This excellent clinical result was naturally sorted into documents and sent to Chen Changan.

At the same time, the third phase of clinical trials are also in full swing.

...........

Ruikang Group Headquarters.

After receiving the clinical data and carefully reviewing it, Chen Changan was also very satisfied.

Judging from the current clinical practice so smoothly, at the end of the years, the Biodynamic Type 1 chip can be launched on the market.

However, he was still considering whether to release other cyber prosthetics together.

The current biodynamic type 1 chip actually meets the minimum demand for controlling Cyborg prosthesis. Cyborg prosthesis such as synthetic lung lobes, paraheart, and strengthening tendons can play a normal role as long as it is implanted into the body of a patient with a biodynamic type 1 chip.

The functions of these prosthetic bodies are very important, no less than giving ordinary people a second life!

Like the secondary heart, it can replace the main heart when the main heart loses function, which is equivalent to a person having two hearts, and one heart can survive strongly without one heart, and wait until the medical staff helps him with surgical treatment.

This was something I didn’t dare to think about before!

Whether for ordinary people or for some police or professional soldiers in dangerous working environments, the importance of this Cyber ​​prosthesis is self-evident.

But Chen Changan had another concern.

The performance of the Biodynamic Type 1 chip is still a bit low after all.

Although it is said that the paraheart can be controlled and the lung lobes can be synthesized, which is a backup prosthetic body for the human body to be used for normal conditions, it is limited to this.

Biodynamic 1 chips cannot control prosthetics such as Qilushi, adrenaline enhancement components, etc. that require long-term work.

After all, the performance is here. It is still possible to control the secondary heart to play a role in a short time in a critical moment.

For prosthetics such as Qilu Siyiyan that lasts more than ten hours a day, they need a chip with biodynamic type 2 or above to be smoothly controlled.

So if we promote the Cyber ​​prosthetic body now, most of the Cyber ​​prosthetic body that Li Yuntong and others have developed will not be introduced to the market for the time being.

Moreover, after the release of the Biodynamic Type 2 chip, it may be necessary to upgrade other users who have eliminated the brain machine chip implanted due to illness.

In Chen Changan's plan, Qilu Yiyan is the product that Ruikang will mainly promote in the future. After all, this product is not only a great role in medical care, but also a very important product at the virtual site level, and will even change the entire human society!

And if it goes well, the biodynamic type 2 chip may be successfully developed within one or two years.

With such a short interval between the two chips, users need to update and undergo another craniotomy surgery, and spend a lot of money to upgrade new products, which will greatly damage the brand image of Ruikang Group.

It will also cause complaints from many people, and there is a feeling that Ruikang deliberately uses garbage products to harvest a wave of leeks and then puts on chips with good performance...

Therefore, after repeated consideration, Chen Changan decided not to release Cyber ​​prosthetics, and this time he focused on the disease treatment function of biodynamic type 1 chip.
Chapter completed!